On November 2, 2021 Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and gaseous NO (gNO) for the treatment of solid tumors, reported that Steve Lisi, Chairman and Chief Executive Officer of Beyond Air, will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference being held from November 30 – December 2, 2021 (Press release, Beyond Air, NOV 2, 2021, View Source [SID1234594138]). Beyond Air will provide a pre-recorded investor presentation and will be available for virtual one-on-one meetings during the conference.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Presentation Details:
Date and Time: Investor presentation will be available for registered attendees via the Piper Sandler conference site from November 22 to December 2, 2021
Participation: Management will participate in additional 1-on-1 meetings virtually
Please contact your representative at Piper Sandler to schedule a virtual one-on-one meeting with Beyond Air during the conference.